U.S. Water Utilities Stock News

Oculis Holding AG recently advanced its neuro-ophthalmology candidate privosegtor (OCS-05) toward registrational PIONEER trials after a positive FDA meeting, while also preparing additional clinical studies for licaminlimab in dry eye disease. This progression signals an effort to build a differentiated ophthalmology pipeline spanning retinal, inflammatory, and neuroprotective conditions with potentially precision-focused therapies. We’ll now examine how advancing privosegtor into late-stage...

In November 2025, Tradeweb Markets reported record total trading volume of US$56.80 trillion and average daily volume of US$2.90 trillion, alongside completing the industry’s first fully electronic on-chain auction for brokered certificates of deposit with Alphaledger’s blockchain technology. These milestones underline how Tradeweb is deepening the electronification of fixed income markets and using blockchain to streamline traditionally manual workflows in bond trading. We’ll explore how...

Dynatrace (DT) just tightened its ties with Google Cloud, stepping in as a launch partner for Gemini CLI extensions and Gemini Enterprise, and that move could subtly reshape how investors think about its AI growth story. See our latest analysis for Dynatrace. That deeper Google Cloud tie up lands after a strong earnings beat and expanded AWS integrations. Yet the share price has a roughly 19% year to date share price decline and three year total shareholder return of about 18%, suggesting...

In December 2025, Rocket Lab Corporation won an up to US$805 million prime contract from the U.S. Space Development Agency to build 18 missile-warning and tracking satellites and also completed the STP-S30 mission for the U.S. Space Force five months ahead of schedule. Together with fresh civil and international wins, these developments mark Rocket Lab’s shift from a small-launch specialist toward a vertically integrated national-security space contractor. We’ll now examine how Rocket...

Earlier this month, SPIE announced a three-year renewable European framework agreement with Tesla to deploy Megapack-based battery energy storage systems, covering engineering, grid connections, and commissioning across its specialist subsidiaries. The deal underlines Tesla’s push to monetise its energy technology beyond vehicles, as grid-scale storage becomes more important for integrating renewable power and maintaining network stability. We’ll now examine how Musk’s renewed pay package...

Hawaiian Electric Industries (HE) is back in focus as it prepares to join the S&P SmallCap 600 on December 22, 2025, even while Maui wildfire litigation and clean energy investments shape its longer term risk profile. See our latest analysis for Hawaiian Electric Industries. The stock has been choppy lately, with a 1 day share price return of minus 6.24 percent, but a year to date share price return of 20.85 percent suggests tentative momentum as investors weigh wildfire liabilities against...

Earlier this week, Amazon announced new Business Prime benefits that include discounted access to Intuit’s QuickBooks Online Simple Start, alongside offers from CrowdStrike and Gusto, aimed at helping small and midsize businesses manage finances, cybersecurity, and HR more efficiently. A separate multi-year partnership with Circle to integrate USDC stablecoin infrastructure across Intuit’s platforms positions the company to modernize payments and refunds with faster, lower-cost, programmable...

First Horizon (FHN) has been quietly grinding higher, with the stock up about 2% in the past day, 4% this week, and roughly 12% over the past month as investors revisit regional banks. See our latest analysis for First Horizon. Zooming out, First Horizon’s share price has climbed steadily this year, with a strong year to date share price return and a solid one year total shareholder return suggesting momentum is quietly rebuilding as investors reassess regional bank risk and growth...

In December 2025, MyOme announced a collaboration and investment from Illumina to support its Proactive Health Trial, which will test whole-genome sequencing combined with AI-integrated risk models across common, chronic, and rare diseases, with enrollment expected to start in 2026. This partnership links Illumina’s population-scale sequencing capabilities with MyOme’s AI-driven risk assessment tools, highlighting a push toward earlier, more personalized interventions that aim to cut a very...

Martin Marietta Materials (MLM) has quietly kept climbing, with shares up about 5% over the past month and nearly 24% this year, as investors focus on steady infrastructure and construction demand. See our latest analysis for Martin Marietta Materials. At around $633.94 a share, that solid year to date share price return of roughly 24% and a three year total shareholder return near 91% suggest investors are steadily pricing in durable infrastructure growth rather than a one quarter story. If...

If you are looking at Venture Global and wondering whether the recent slump has quietly turned it into a value play, you are not alone. The stock has bounced 3.3% over the last week even after a steep 12.4% drop over 30 days and a bruising 73.5% slide year to date. This combination often signals the market is rapidly reassessing both its growth prospects and risk profile. Recent headlines around Venture Global have centered on shifting investor sentiment in the LNG and broader energy space,...

LendingClub (LC) just delivered a stronger quarter, with revenue and net income up solidly from last year, and that combination of earnings momentum and heavy loan demand is starting to reshape how investors view the stock. See our latest analysis for LendingClub. The upbeat quarter lands on top of an already strong run, with a roughly 21.8% year to date share price return and a powerful three year total shareholder return of about 126.6% suggesting momentum is firmly building. If...

If you are wondering whether CME Group is still worth buying after its long run, or if the market has already priced in the upside, you are not alone. That is exactly what we are going to unpack here. The stock has slipped around 1.6% over the last week and 1.5% over the past month, but it is still up 15.6% year to date and 17.8% over the last year, with multi year returns above 78% over three years and 82.2% over five years. Recent market attention has centered on CME as a key beneficiary...

Evolv Technologies Holdings (EVLV) is back in the spotlight after announcing its Evolv Express systems are being installed at the 14,000 seat Pechanga Arena San Diego, further extending its footprint across major California venues. See our latest analysis for Evolv Technologies Holdings. That expanding customer list seems to be feeding into sentiment, with the share price at $7.21 and a strong year to date share price return alongside a robust one year total shareholder return, suggesting...

Amgen (AMGN) just checked two big boxes at once, tightening its partnership with Washington on drug pricing while winning FDA approval for UPLIZNA in generalized myasthenia gravis, and the stock is reacting accordingly. See our latest analysis for Amgen. That backdrop of tariff relief and drug price cooperation, combined with the fresh UPLIZNA approval, comes on top of a strong run, with Amgen’s share price up 26.27% year to date and a 5 year total shareholder return of 71.89%, which suggests...

Celanese (CE) has had a choppy year in the market, with the stock sliding sharply year to date even as revenue edges higher and net income rebounds from a deep loss. Investors are now reassessing what that disconnect really means. See our latest analysis for Celanese. At around $42.29 per share, Celanese’s 11.49% 1 month share price return looks like a short term bounce within a much tougher backdrop. The 5 year total shareholder return is still deeply negative and momentum appears more...

Triumph Financial (TFIN) is back in the spotlight after BlueGrace Logistics joined the Triumph Network, a move that tightens Triumph’s grip on fintech powered freight payments and back office automation. See our latest analysis for Triumph Financial. The BlueGrace deal comes as Triumph’s 30 day share price return of 15.91% and 90 day share price return of 12.26% clash with a much weaker year to date share price return of minus 30.07%. However, the three year total shareholder return of 25.55%...

Earlier in December 2025, Azenta, Inc. announced a US$250,000,000 share repurchase program running through 2028 and, at its Investor Day, outlined plans to deploy its balance sheet toward disciplined M&A focused on high-margin, recurring-revenue life sciences assets. Management highlighted a funnel of about 60 potential acquisition targets and emphasized strict financial filters, including margin accretion, double-digit ROIC within three to five years, and a bias toward tuck-in deals in...

Earlier in December 2025, the U.S. FDA issued a warning letter to Target after recalled ByHeart Whole Nutrition Infant Formula linked to an infant botulism outbreak remained on sale in multiple Target stores across 20 states despite recall notices. The letter highlights not just product safety concerns but also serious weaknesses in Target’s recall execution and regulatory communications, raising questions about its internal controls for high-risk consumer goods. We’ll now examine how this...

Kimberly-Clark (KMB) has been sliding lately, with the stock down about 4% over the past month and almost 19% in the past 3 months, even as earnings and revenue continue to grow. See our latest analysis for Kimberly-Clark. That slide comes after a tougher stretch for Kimberly-Clark, with the share price returning about negative 23 percent year to date and total shareholder return down roughly 20 percent over the past year. This suggests momentum has clearly faded despite improving...

In recent weeks, XPEL outlined an ambitious US$75–US$150 million capital expenditure plan over the next two years while insiders increased their shareholdings, and an analyst cited potential margin gains as reinforcing the company’s operational strength. This combination of growth investment, insider buying, and confidence in profitability sends a strong signal about how management views XPEL’s long‑term positioning in the paint protection and automotive personalization market. We’ll now...

In recent weeks, Li Auto has faced its first quarterly loss after 11 profitable quarters, hit by a recall of its MEGA model, weaker sales and margins, and analyst downgrades, even as it gained approval to test Level 3 autonomous driving in Beijing. At the same time, Li Auto has accelerated its overseas push into Egypt, Kazakhstan, and Azerbaijan and opened new global AI R&D hubs, signaling a bid to offset domestic pressure with international growth and smarter driving technology. We’ll now...

Earlier this month, EMASS announced a collaboration with Semtech to integrate Semtech’s LoRa transceivers into EMASS’s ECS-DoT low-power edge AI SoCs, enabling long-range, battery-efficient intelligence for industrial, IoT, and security applications and showcasing multiple real-world reference designs at CES 2026 venues including Semtech’s and the LoRa Alliance’s locations. This partnership reinforces Semtech’s push to pair its LoRaWAN connectivity with edge AI processing, aiming to reduce...

Earlier this month, Stewart Information Services completed a follow-on equity offering of 1,900,000 common shares at US$68, raising about US$129.2 million, while also filing an omnibus shelf registration covering common and preferred stock, warrants, units, debt securities and purchase contracts. This combination of fresh equity capital and expanded financing flexibility could meaningfully influence investor views on dilution, balance sheet strength and future funding options. Next, we’ll...